Features
Peripheral Retinal Changes in AMD
Consider more than the macula.
By Melissa Yuan, MD, Ines Lains, MD, PhD
Retinal Biomarkers for Alzheimer Disease
Retinal imaging metrics have the potential to provide valuable insights.
By Meredith Cox, BS, MS, Terry Lee, MD, Dilraj S. Grewal, MD, FASRS, et al.
Insightful Imaging for Geographic Atrophy
Maximize the effective use of tools for lesion detection and quantification.
By Brian Solinsky, MD, Eliza Broadbent, BS, Elias Siltanen, BS, et al.
Use of OCT Macular Volume Scan in Uveitic Retinal Vasculitis
Multimodal imaging helps assess uveitic vascular leakage.
By Tedi Begaj, MD, Akhila Alapati, MD, Saleema Kherani, MD, et al.
Web Exclusives
Artificial Intelligence to Manage the AMD Burden
A partnership between humans and technology has great potential for disease screening.
By William Haseltine, PhD, Kim Hazel, MPH
Therapies for Geographic Atrophy: Safety First
It is advisable to apply some precautionary protocols when selecting patients for GA therapy.
By Hashem Ghoraba, Sumit Sharma, MD
Acute CSCR and NSAID Drops: A Message Worth Repeating
NSAIDs, which are used to treat central macular edema (CME) and diabetic macular edema (DME), might work in some CSCR cases
By Michael A. Singer, MD
Retinal Physician eUpdate - February 16, 2024
By Steve Lenier
Breaking News: 12-month Data for Faricimab for Retinal Vein Occlusion
Dr. Tadayoni and Dr. Singer discuss the latest data from the BALATON and COMINO trials
By Ramin Tadayoni, MD, PhD, Michael A. Singer, MD
A Summary of the MERIT Trial: Intravitreal Therapy for Uveitic Macular Edema
Uveitis comes with its own unique set of challenges and visually devastating complications, especially macular edema
By Sruthi Arepalli, MD
Departments
UPFRONT: Windows to Our Health
By Peter K. Kaiser, MD
Coding Q&A: What’s New in Retina Coding for 2024
Revised E/M code descriptions and a new CPT code for suprachoroidal injections are among the changes.
By Brandy H. Sperry, COMT, COE, CPC, CPMA
CONTROVERSIES IN CARE: Withdrawal of Anti-VEGF Agents in Neovascular AMD
Should it be a goal?
By Michael Colucciello, MD, Anat Loewenstein, MD, MHA, Diana V. Do, MD
NEW PRODUCT APPLICATIONS: Solix Provides Multiple Imaging Platforms in One Machine
Device improves diagnostic accuracy and efficiency.
By Karen Appold, contributing writer
Clinical Trial Download: Longer-term Data on New Treatments for Geographic Atrophy
Nuances from extension studies will inform therapeutic decision-making.
By Yasha Modi, MD , Vaidehi S. Dedania, MD
News
EyePoint Reports Positive Results of Phase 2 Trial for Investigational AMD Treatment
EYP-1901 met all primary endpoints in the DAVIO 2 clinical trial.
By Jim Gallagher, senior managing editor
Subspecialty News January/February 2024
Vabysmo approved for RVO, Byooviz approved as interchangeable with Lucentis, and more.
By Rochelle Nataloni, contributing writer